Forte Biosciences (FBRX) Competitors $11.38 +0.83 (+7.81%) As of 02:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock FBRX vs. KOD, ATYR, AQST, ESPR, IVA, RAPP, CYRX, ZVRA, PRME, and BCYCShould you be buying Forte Biosciences stock or one of its competitors? The main competitors of Forte Biosciences include Kodiak Sciences (KOD), aTyr Pharma (ATYR), Aquestive Therapeutics (AQST), Esperion Therapeutics (ESPR), Inventiva (IVA), Rapport Therapeutics (RAPP), CryoPort (CYRX), Zevra Therapeutics (ZVRA), Prime Medicine (PRME), and Bicycle Therapeutics (BCYC). These companies are all part of the "pharmaceutical products" industry. Forte Biosciences vs. Its Competitors Kodiak Sciences aTyr Pharma Aquestive Therapeutics Esperion Therapeutics Inventiva Rapport Therapeutics CryoPort Zevra Therapeutics Prime Medicine Bicycle Therapeutics Forte Biosciences (NASDAQ:FBRX) and Kodiak Sciences (NASDAQ:KOD) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings. Does the media prefer FBRX or KOD? In the previous week, Kodiak Sciences had 3 more articles in the media than Forte Biosciences. MarketBeat recorded 9 mentions for Kodiak Sciences and 6 mentions for Forte Biosciences. Forte Biosciences' average media sentiment score of 1.44 beat Kodiak Sciences' score of 1.17 indicating that Forte Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Forte Biosciences 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Kodiak Sciences 5 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is FBRX or KOD more profitable? Forte Biosciences' return on equity of -85.38% beat Kodiak Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Forte BiosciencesN/A -85.38% -72.34% Kodiak Sciences N/A -155.27%-63.29% Do analysts rate FBRX or KOD? Forte Biosciences presently has a consensus target price of $68.00, suggesting a potential upside of 497.28%. Kodiak Sciences has a consensus target price of $11.75, suggesting a potential upside of 25.55%. Given Forte Biosciences' stronger consensus rating and higher probable upside, research analysts plainly believe Forte Biosciences is more favorable than Kodiak Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Forte Biosciences 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Kodiak Sciences 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has higher earnings and valuation, FBRX or KOD? Kodiak Sciences is trading at a lower price-to-earnings ratio than Forte Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioForte BiosciencesN/AN/A-$35.48M-$16.29-0.70Kodiak SciencesN/AN/A-$176.21M-$3.80-2.46 Which has more risk & volatility, FBRX or KOD? Forte Biosciences has a beta of 2.69, suggesting that its stock price is 169% more volatile than the S&P 500. Comparatively, Kodiak Sciences has a beta of 2.44, suggesting that its stock price is 144% more volatile than the S&P 500. Do insiders & institutionals hold more shares of FBRX or KOD? 77.6% of Forte Biosciences shares are held by institutional investors. Comparatively, 89.1% of Kodiak Sciences shares are held by institutional investors. 5.9% of Forte Biosciences shares are held by company insiders. Comparatively, 45.9% of Kodiak Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryForte Biosciences beats Kodiak Sciences on 8 of the 13 factors compared between the two stocks. Get Forte Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for FBRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FBRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FBRX vs. The Competition Export to ExcelMetricForte BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$140.21M$3.11B$5.75B$10.27BDividend YieldN/A2.32%5.73%4.60%P/E Ratio-0.6921.4175.1826.37Price / SalesN/A240.50457.0688.69Price / CashN/A44.4425.8129.91Price / Book1.399.6113.256.28Net Income-$35.48M-$53.20M$3.29B$270.67M7 Day Performance2.29%0.18%0.72%2.79%1 Month Performance-1.60%4.02%4.58%6.01%1 Year Performance56.39%9.21%73.44%26.05% Forte Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FBRXForte Biosciences3.3732 of 5 stars$11.39+7.8%$68.00+497.3%+45.1%$140.21MN/A-0.695Positive NewsKODKodiak Sciences3.8416 of 5 stars$9.79-6.9%$11.75+20.0%+241.3%$555.68MN/A-2.5890News CoverageATYRaTyr Pharma2.7486 of 5 stars$5.46-2.7%$23.25+325.8%+217.4%$549.71M$230K-6.8253Trending NewsAnalyst ForecastGap DownTrading HaltedAQSTAquestive Therapeutics2.2065 of 5 stars$5.01-7.6%$10.29+105.3%+4.3%$540.50M$57.56M-7.16160ESPREsperion Therapeutics4.012 of 5 stars$2.51-6.3%$7.00+178.9%+48.7%$540.35M$332.31M-5.12200Positive NewsIVAInventiva2.9812 of 5 stars$5.37-3.6%$14.83+176.2%+150.4%$532.84M$9.95M0.00100Short Interest ↑Gap DownRAPPRapport Therapeutics2.6712 of 5 stars$31.47+119.2%$31.00-1.5%+25.1%$524.11MN/A-12.59N/AAnalyst UpgradeHigh Trading VolumeCYRXCryoPort3.844 of 5 stars$10.04-3.0%$12.00+19.5%+3.5%$518.19M$228.38M7.551,186Positive NewsInsider TradeZVRAZevra Therapeutics3.0105 of 5 stars$8.33-6.9%$23.71+184.7%-1.3%$502.41M$23.61M-39.6720Analyst DowngradePRMEPrime Medicine3.4191 of 5 stars$3.89+4.6%$8.92+129.2%-0.5%$500.62M$4.96M-1.90234Gap UpBCYCBicycle Therapeutics3.1056 of 5 stars$7.00-2.2%$22.22+217.5%-73.8%$495.86M$35.28M-1.99240 Related Companies and Tools Related Companies KOD Competitors ATYR Competitors AQST Competitors ESPR Competitors IVA Competitors RAPP Competitors CYRX Competitors ZVRA Competitors PRME Competitors BCYC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FBRX) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Forte Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Forte Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
